Infertility Treatment Devices Market

Global Infertility Treatment Devices Market:

The global infertility treatment devices market size reached US$ 450.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 729.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The rising infertility rates, ongoing technological advancements, the growing trend of delayed parenthood, and numerous government initiatives are primarily driving the market's growth.

Infertility Treatment Devices Market Analysis:

• Major Market Drivers: The increasing number of fertility clinics across the globe represents one of the key factors propelling the growth of the market. Moreover, lack of physical activities on account of sedentary lifestyles has led to the development of chronic diseases, such as diabetes, obesity, and hypertension, which are potential risk factors leading to infertility among men and women, thereby escalating the infertility treatment devices market growth.
• Key Market Trends: There is a rise in the use of ART procedures, such as IVF, which involves the utilization of previously frozen embryos and donor eggs or sperm. This, coupled with the growing availability of numerous infertility treatment devices, is positively influencing the market. Additionally, declining fertility rates, rising public-private investments, and numerous government initiatives to increase the accessibility of infertility treatments are contributing to the infertility treatment devices market share.
• Competitive Landscape: Some of the prominent infertility treatment devices market companies include Ab Scientific Ltd, Cook Group Incorporated, Coopersurgical Inc. (The Cooper Companies Inc.), Eppendorf, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne Ltd., Kitazato Corporation, Rocket Medical plc, Thermo Fisher Scientific, Thomas Medical (Medgyn Products Inc.), and Vitrolife, among many others.
• Geographical Trends: According to the infertility treatment devices market dynamics, North America is a hub for innovations in medical devices, with cutting-edge infertility treatments such as in vitro fertilization (IVF) and intrauterine insemination (IUI) equipment. Moreover, many European countries, such as the UK, France, and Germany, provide government support for fertility treatments, including reimbursement policies and public funding for IVF procedures, further driving the infertility treatment devices market growth.
• Challenges and Opportunities: The high cost of treatments and devices and lack of insurance coverage are hampering the market's growth. However, globally, infertility rates are rising due to various factors like lifestyle changes, increasing maternal age, stress, obesity, smoking, and environmental factors. This increase in infertility cases presents a substantial opportunity for companies providing infertility treatment devices.
   

Infertility Treatment Devices Market Trends:

Rising Prevalence of Infertility

A significant increase in infertility rates globally, driven by lifestyle changes such as delayed childbearing, obesity, stress, smoking, and environmental factors (pollution, toxins, etc.), is a major growth driver. For instance, according to the World Health Organization (WHO), infertility affects approximately 17.5% of the adult population or roughly one in every six people in the world.  Similarly, according to a Single Care article, approximately 12% to 15% of couples are unable to conceive after one year of trying. This rising prevalence creates a growing demand for infertility treatments. These factors are expected to propel the infertility treatment devices market share in the coming years.

Surging Government Initiatives

Government initiatives to improve access to reproductive health services and support fertility treatments in various developing nations are driving the market's growth. Some governments offer subsidies or provide financial assistance for infertility treatments. For instance, in February 2024, government-run medical colleges and hospitals (GMCH) in Maharashtra announced to provide high-priced IVF treatment to infertile couples, valued at over INR 2 lakhs in private clinics, at zero cost.  These factors further positively influence the infertility treatment devices market size.

Technological Innovations

Technological innovations in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and cryopreservation, have significantly improved the success rates of infertility treatments, encouraging more couples to seek these treatments. For instance, in July 2024, Nikon Corporation (Nikon) unveiled the ECLIPSE Ti2-I Motorized Inverted Microscope for ICSI*3/IMSI*4, which is designed for use in micro-insemination. It can be automatically adjusted by simple buttons and a touch screen close to the hands, decreasing the number of steps necessary to operate by about 75%, thereby boosting the infertility treatment devices market share.

Global Infertility Treatment Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility treatment devices market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, patient type, and end user.

Breakup by Type:

• Sperm Separation Devices
• Ovum Aspiration Pumps
• Sperm Analyzer Systems
• Micromanipulator Systems
• Incubators
• Cryosystems
• Imaging Systems
• Microscopes
• Others
   

The report has provided a detailed breakup and analysis of the infertility treatment devices market based on the type. This includes sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscopes, and others. 

According to the infertility treatment devices market outlook, the rising cases of male infertility due to factors like lifestyle, environmental toxins, and health conditions are driving demand for sperm separation devices. These devices help in isolating healthy sperm for use in assisted reproductive techniques like ICSI and IVF. Moreover, ovum aspiration is a critical step in IVF. The increasing number of IVF cycles performed annually is a significant driver for the demand for ovum aspiration pumps. Furthermore, with male infertility contributing to nearly 40-50% of all infertility cases, sperm analyzers are in high demand to assess sperm count, motility, morphology, and viability.

Breakup by Patient Type:

• Female Infertility Treatment 
• Male Infertility Treatment
   

The report has provided a detailed breakup and analysis of the infertility treatment devices market based on the patient type. This includes female infertility treatment, and male infertility treatment.

According to the infertility treatment devices market overview, women are increasingly choosing to delay motherhood due to career, education, or financial reasons. As maternal age increases, fertility typically declines, leading to higher demand for fertility treatments like in vitro fertilization (IVF), egg freezing, and ovulation stimulation. Moreover, conditions like polycystic ovary syndrome (PCOS), endometriosis, and premature ovarian failure are on the rise, contributing to infertility among women. These conditions often require medical interventions such as hormone therapy and ART procedures, driving the demand for female infertility treatments. Furthermore, there is a growing awareness that male infertility is as significant as female infertility. This has led to an increase in sperm analysis, hormonal assessments, and genetic testing for men, contributing to the demand for diagnostic tools like sperm analyzers, testicular biopsy tools, and micromanipulation systems.

Breakup by End User:

• Fertility Clinics
• Hospitals and Other Healthcare Facilities
• Clinical Research Institutes
   

The report has provided a detailed breakup and analysis of the infertility treatment devices market based on the end user. This includes fertility clinics, hospitals and other healthcare facilities, and clinical research institutes.

Fertility clinics are the main providers of assisted reproductive technologies (ART) such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and embryo freezing, leading to high demand for specialized devices like sperm separation devices, incubators, cryosystems, and microscopes. Moreover, hospitals provide a broad range of medical services, including initial infertility diagnosis and treatments such as hormone therapies, minor surgical procedures for reproductive health, and consultations. Devices like sperm analyzers, microscopes, and imaging systems are often in demand for diagnostic purposes. Furthermore, research institutes are involved in developing and testing innovative fertility devices and new ART techniques, leading to demand for experimental or high-end devices like micromanipulators, incubators, sperm separation devices, and advanced imaging systems. These devices are essential for in-vitro research on embryo development, gamete quality, and reproductive health.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the infertility treatment devices market statistics, the growing incidence of infertility, especially due to lifestyle factors like obesity, stress, and delayed parenthood, is driving demand for infertility treatments and devices in North America region. Moreover, Europe has seen a notable rise in infertility due to factors like delayed parenthood, lifestyle changes, and declining fertility rates, driving demand for fertility treatment devices. Besides this, the large population base in Asia Pacific, combined with rising infertility rates due to lifestyle factors, delayed marriages, and urbanization, creates a significant market for fertility treatments and devices in the region.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: 

• Ab Scientific Ltd
• Cook Group Incorporated
• Coopersurgical Inc. (The Cooper Companies Inc.)
• Eppendorf
• Esco Micro Pte. Ltd.
• Genea Limited
• Hamilton Throne Ltd.
• Kitazato Corporation
• Rocket Medical plc
• Thermo Fisher Scientific
• Thomas Medical (Medgyn Products Inc.)
• Vitrolife
   

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Infertility Treatment Devices Market Recent Developments:

• July 2024: Nikon Corporation (Nikon) unveiled the ECLIPSE Ti2-I Motorized Inverted Microscope for ICSI*3/IMSI*4, which is designed for use in micro-insemination. It can be automatically adjusted by simple buttons and a touch screen close to the hands, decreasing the number of steps necessary to operate by about 75%.
• July 2024: Mira, a hormonal health company that provides at-home reproductive health solutions, established an online Hormone Health Clinic for Fertility to aid those who are having difficulty conceiving.
• May 2024: May Health raised $25 million in funding to support clinical trials of its less invasive, outpatient method for treating infertility caused by polycystic ovarian syndrome, also known as PCOS.

Infertility Treatment Devices Market Report Scope:

Key Questions Answered in This Report

• How has the global infertility treatment devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global infertility treatment devices market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the patient type?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global infertility treatment devices market and who are the key players?
• What is the degree of competition in the industry? 

Key Benefits for Stakeholders:

• IMARC's report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the infertility treatment devices market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global infertility treatment devices market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the infertility treatment devices industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.